Mst3b mediates the response of retinal ganglion cells (RGCs) to growth factors. (a–g) Representative photos of RGCs transfected with plasmids expressing the shRNA constructs and/or Mst3b variants shown on the left. Cells were exposed to media alone or to a combination of oncomodulin, mannose, and forskolin (Ocm/m/f) as indicated. Cells were fixed 3 days later and immunostained for EGFP, a marker for transfected cells, and either βIII-tubulin, a marker for RGCs (antibody TuJ1), or the myc-his-tag present on recombinant human Mst3b. (h) Quantitation of axon outgrowth. RGCs transfected with control shRNA extended axons when exposed to Ocm/m/f (a,b,h), whereas cells expressing mst3b shRNA did not (c,h). Outgrowth was restored when RGCs expressing mst3b shRNA were co-transfected with a plasmid expressing his-tagged human Mst3b (d,h). Expression of human Mst3b was verified by immunostaining for the his tag (e). Expression of kinase-dead (k/d) Mst3b blocked the effects of growth factors (f,h), whereas expression of constitutively active (c/a) Mst3b resulted in outgrowth even with growth factors absent (g,h). Scale bar for a–g: 40 μm. Each experiment included 4 blinded, independent observations (10–100 cells per well), and each experiment was repeated 3 times. *, **, ***increase relative to untreated controls significant at P < 0.05, P < 0.01, or P < 0.001, respectively. †††decrease relative to control cells treated with growth factors significant at P < 0.001. Error bars represent s.e.m.